Skip to content
US High-rise buildings

August Earnings: Eli Lilly, Amgen, Warner Bros.

Over the last two weeks, the number of corporations reporting positive earnings surprises has increased. As a result, the second-quarter earnings growth rate was greater in the last week of July compared to the prior weeks. Investors are optimistic that the trend will continue when the first week of August comes to a finish. Here are some reports and expectations for the week.

Eli Lilly and Company

Eli Lilly & Company is set to announce earnings before the market opens on August 4, 2022. The report will cover the fiscal quarter that ends in June 2022. According to investment researchers, the consensus EPS projection for the quarter is $1.8, based on expert forecasts.

The reported earnings per share for the same quarter last year were $1.87.

Amgen Inc.

Amgen Inc. reported that its Board of Directors has declared a dividend of $1.94 per share for the third quarter of 2022. The dividend will be paid to all stockholders of record as of the close of business on August 18, 2022, on September 8, 2022.

AMGN) also announced the immediate appointment of Michael V. Drake, M.D. to its Board of Directors. 

Dr. Drake will also serve on the Corporate Responsibility and Compliance Committee of the Board, as well as the Governance and Nominating Committee. Following Dr. Drake’s appointment, the Board will consist of 13 directors, 12 of whom are independent. 

Warner Bros. Discovery, Inc.

On August 4, 2022, following market close, Warner Bros. Discovery, Inc. is anticipated to release financial results. The financial quarter covered by the report ended in June 2022. According to investment analysts, the consensus EPS expectation for the quarter is $0. 

This is based on 4 analysts’ predictions. For the same quarter the previous year, there was a reported EPS of $0.83.

Disclaimer:
All information has been prepared by TraderFactor or partners. The information does not contain a record of TraderFactor or partner’s prices or an offer of or solicitation for a transaction in any financial instrument. No representation or warranty is given as to the accuracy or completeness of this information. Any material provided does not have regard to the specific investment objective and financial situation of any person who may read it. Past performance is not a reliable indicator of future performance.

Author

  • Phyllis Wangui

    Phyllis Wangui is a Financial Analyst and News Editor with qualifications in accounting and economics. She has over 20 years of banking and accounting experience, during which she has gained extensive knowledge of the forex, stock news, stock market, forex analysis, cryptos and foreign exchange industries. Phyllis is an avid commentator on these topics and loves to share her insights with others through financial publications and social media platforms.

    View all posts